Summary
Progestin, estrogen, androgen, glucocorticoid as well as mineralocorticoid receptors (PR, ER, AR, GR and MR, respectively) were all evaluated with specific synthetic radioligands (biochemical assays) in 25 meningiomas, 9 gliomas and 4 brain metastases. In meningiomas the main steroid hormone receptors appeared to be the progestin receptor, present in 24/25 cases (mean level: 7 105 fmol/ gT) and the androgen receptor, present in 23/25 cases (mean level: 2 265 fmol/ gT). Progestin receptor levels were found to be significantly lower in meningiomas of the fibroblastic subtype whereas none of the steroid hormone receptors were detected in the anaplastic case. On the other hand, glucocorticoid receptor levels were related to the preoperative glucocorticoid therapy. In gliomas only estrogen receptors (2/9 cases) and especially androgen receptors (8/9 cases) were noticeable: the latter seemed to be related to the histological types and to the sex of patients. No receptors were found in any of the four studied metastases, including one from breast cancer. The biochemical characterization of the receptors as well as their relevance to tumor biology and to the physiology of the normal tissues where tumors arise, were discussed, and biochemical data were compared with those previously reported.
Similar content being viewed by others
References
Donnell MS, Meyer GA, Donegan WL: Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50:499–502, 1979.
Poisson M, Magdelenat H, Foncin JF, Bleibel JM, Philippon J, Pertuiset B, Buce A: Récepteurs d'oestrogène et de progesterone dans les meningiomas. Etude de 22 cas. Rev Neurol (Paris) 136:193–203, 1980.
Johnson FE, Rosen PP, Menendez-Botet C, Schwartz MK, Ashikari R, Kinne DW: Estrogen receptor protein in visceral metastases from breast carcinoma. Am J Surg 142:252–254, 1981.
Kasantikul V, Brown WJ: Estrogen receptors in acoustic neurilemmoma. Surg Neurol 15:105–109, 1981.
Schnegg JF, Gomez F, Lemarchand-Beraud T, de Tribolet N: Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 15:415–418, 1981.
Martuza RL, Mac Laughin DT, Ojeman RG: Specific estradiol binding in schwannomas, meningiomas and neurofibromas. Neurosurgery 9:665–671, 1981.
Rengacharay SS, Tilzer LL: A study of dexamethasone receptor protein in human gliomas. J Surg Res 31:447–455, 1981.
Yu ZY, Wrange O, Boethius J, Hatam A, Granholm L, Gustafsson JA: A study of glucocorticoid receptors in intracranial tumors. J Neurosurg 55:757–760, 1981.
Yu ZY, Haglund B, Granholm L, Gustafsson JA: Estrogen and progestin receptors in intracranial meningiomas. J Steroid Biochem 16:451–456, 1982.
Tilzer LL, Plapp FV, Evans JP, Stone D, Award K: Steroid receptor proteins inhuman meningiomas. Cancer 49:633–636, 1982.
Magdelenat H, Pertuiset BF, Poisson M, Martin PM, Philippon J, Pertuiset B, Buge A: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir 64: 199–213, 1982.
Zulch KJ: Brain tumors. Their biology and pathology. Springer Publishing Company, New York, 1965, p 66.
Jellinger K: Glioblastoma multiforme. Morphology and biology. Acta Neurochir 42:5–32, 1978.
Dimant IN, Loktionov GM, Staev MM, Israilyan AA: Further study of induction of brain tumors in rats by Methylnitrosourea. Bull Exp Biol Med 69:566–568, 1970.
Hopewell JW: The hormone dependance of experimentally induced gliomas in the rat. Neuropathol Appl Neurobiol 1:141–148, 1975.
Zulch KJ: Histological classification of tumors of the central nervous system. WHO, Geneva, 1979.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 72:248–254, 1976.
Fiszer-Szafarz B, Szafarz D, Guevara de Murillo A: A general, fast and sensitive micromethod for DNA determination. Ana Biochem, 110:165–170, 1981.
Raynaud JP, Ojasoo T, Bouton MM, Philibert D: Receptor binding as a tool in the development of new bioactive steroids. In: Ariens EJ (ed) Drug design, vol VIII. Academic Press, New York, 1979, pp 169–214.
Ojasoo T, Raynaud JP: Unique steroid congeners for receptor studies. Cancer Res 38:4186–4198, 1978.
Zava DT, Landrum B, Horwitz KB, McGuire WL: Androgen receptor assay with (3H)methyltrienolone (R 1881) in the presence of progesterone receptors. Endocrinology 104: 1007–1012, 1979.
Asselin J, Melancon R, Gourdeau T, Labrie F, Bonne C, Raynaud JP: Specific binding of 3H-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). J Steroid Biochem 10:483–486, 1979.
Raynaud JP, Bouton MM, Martin PM: Human prostate hyperplasia and adenocarcinoma: steroid hormone receptor assays and therapy. In: Schröder FH, de Voogt HJ (eds) Steroid receptors, metabolism and prostatic cancer. Excerpta Medica, Amsterdam, 1980, pp 165–181.
Moguilewsky M, Raynaud JP: Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J Steroid Biochem 12:309–314, 1980.
Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672, 1949.
Moguilewsky M, Raynaud JP: Estrogen sensitive progestin binding sites in the female rat brain and pituitary. Brain Res 164:165–175,1979.
Westphal V: Steroid-Protein interactions. Springer-Verlag, Berlin, 1971, p 356.
Raynaud JP, Martin PM, Bouton MM, Ojasoo T: 11β-methoxy-17-ethynyl-1, 3, 5 (10)-estratriene-3, 17β-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues. Cancer Res 38:3044–3050, 1978.
McEwen BS, Wallach G, Magnus C: Corticocosterone binding to hippocampus: immediate and delayed influences of the absence of adrenal secretion. Brain Res 70:321–334, 1974.
McGuire WL: Steroid receptors in human breast cancer. Cancer Res 38:4289–4291, 1978.
Ramanath Rao B, Meyer JS, Glenn Fry C: Most cystosarcoma phyllodes and fibroradenomas have progesterone receptor but lack estrogen receptor. Cancer 47:2016–2021, 1981.
MacLusky NJ, McEwen BS: Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 274:276–278, 1978.
Blaustein JD, Wade GN: Progestin binding by brain and pituitary cell nuclei and female rat sexual behavior. Brain Res 140:360–367,1978.
Russel DS, Rubinstein LJ: Pathology of tumors of the nervous systeme. Edward Arnold, London, 1977, pp 65–100.
Nystrom SHM: A study on supratentorial meningiomas with special reference to gross and fine structure. Acta Pathol Microbiol Scand (Suppl) 176:1–90, 1965.
Escourolle R, Poirier J: Etude en microscopie électronique des tumeurs du systeme nerveux. Neuro chirurgie (suppl 1): 25–49,1971.
Bailey OT: Histologic sequences in the meningioma with a consideration of the nature of hyperostosis cranii. Arch Pathol 30:42–69,1940.
Rascol M, Izard J, Jorda P, Rascol A: Etude ultrastructurale des méningiomas. Rev Med Toulouse 1:621–640, 1965.
Napolitano L, Kyle R, Fisher ER: Ultrastructure of meningiomas and the derivation and nature of their cellular components. Cancer 17:233–241, 1964.
Jellinger K, Slowik F: Histological subtypes and pronostic problemes in meningiomas. J Neurol 208:279–298, 1975.
Roth JG, Elvidge AR: Glioblastoma multiforme: A clinical survey. J Neurosurg 17:736–750, 1960.
Janisch W, Schreiber D: Experimental brain tumors. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 17/11. North-Holland, Amsterdam, 1974, pp 1–41.
Stewart J F, King RJB, Sexton SA, Millis RR, Ruben RDD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer 17:449–453, 1981.
Author information
Authors and Affiliations
Additional information
Address for reprints: M. Poisson, Clinique Neurologique, Hôpital de la Salpetriere, 75651 Paris Cedex 13, France
Rights and permissions
About this article
Cite this article
Poisson, M., Pertuiset, B.F., Hauw, JJ. et al. Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neuro-Oncol 1, 179–189 (1983). https://doi.org/10.1007/BF00165601
Issue Date:
DOI: https://doi.org/10.1007/BF00165601